Showing results (1-10 of 196) with videos related to
Sort By:
Pageof 20
Food and Drug Law Journal|December 4, 2015
FDA Adverse Event Reporting System: Recruiting Doctors to Make Surveillance a Little Less PassiveJustin M MannFood and Drug Law Journal|May 7, 2005
Legal implications of pharmacogenomics regarding drug trials, drug labeling, and genetic testing for drug prescription: an international approachTilo MandryFood and Drug Law Journal|May 7, 2005
2004 update--180-day exclusivity under the Hatch-Waxman amendments to the federal Food, Drug, and Cosmetic ActErika King LietzanFood and Drug Law Journal|December 17, 2009
Problems associated with direct-to-consumer advertising (DTCA) of restricted, implantable medical devices: should the current regulatory approach be changed?Bruce PatsnerFood and Drug Law Journal|December 17, 2009
Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-ShelhighEdward M Basile, Deborah Tolomeo, Elizabeth GluckFood and Drug Law Journal|December 17, 2009
FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reformBenjamin R RossenFood and Drug Law Journal|December 17, 2009
Life after Riegel: a fresh look at medical device preemption one year after Riegel v. Medtronic, IncGregory J WartmanFood and Drug Law Journal|December 17, 2009
Casting a global safety net--a framework for food safety in the age of globalizationJames ChyauFood and Drug Law Journal|December 17, 2009
Cloned animal products in the human food chain: FDA should protect American consumersJennifer E F ButlerFood and Drug Law Journal|December 17, 2009
Encouraging research and development of pediatric medical devices through legislative and regulatory action: the Pediatric Medical Device Safety and Improvement Act of 2007 in contextEster W B BleicherPageof 20